BOSA, LUCA

BOSA, LUCA  

Università di Padova  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Case Report: Intestinal Nodular Lymphoid Hyperplasia as First Manifestation of Activated PI3Kδ Syndrome Due to a Novel PIK3CD Variant 2021 Marzollo A.Bresolin S.Cani A.Gaio P.Bosa L.Rossini L.Perilongo G.Biffi A.Cananzi M. + FRONTIERS IN PEDIATRICS - -
Disseminated Mycobacterial Infection With Reactive Polyarthritis (Poncet’s Disease) During Immune-suppressive Treatment Including Ustekinumab for Pediatric Crohn’s Disease 2024 Costenaro, PaolaDona', DanieleBosa, LucaPerilongo, Giorgio + THE PEDIATRIC INFECTIOUS DISEASE JOURNAL - -
Early onset food protein-induced enterocolitis syndrome in two breastfed newborns masquerading as surgical diseases: case reports and literature review 2021 Bosa L.Tardini G.Midrio P. + THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE - -
Feasibility and effectiveness of tuberculosis active case-finding among children living with tuberculosis relatives: A cross-sectional study in Guinea-Bissau 2017 Bosa L.Colombatti R. + MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES - -
Hyperbaric oxygen therapy is an effective adjunctive treatment for severe perianal Crohn's disease 2017 Bosa, L.Gaio, P.Mescoli, C.Perilongo, G.Leon, F. FascettiCananzi, M. + DIGESTIVE AND LIVER DISEASE - -
IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease 2021 Cananzi M.Marzollo A.Bresolin S.Gaio P.Mescoli C.Bosa L.Gabelli M.Perilongo G.Biffi A. + HUMAN GENETICS - -
Point-of-care testing allows successful simultaneous screening of sickle cell disease, HIV, and tuberculosis for households in rural Guinea-Bissau, West Africa 2022 Bosa L.Martella M.Da Dalt L.Reggiani G.Munaretto V.Colombatti R. + PEDIATRIC BLOOD & CANCER - -
Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease 2022 Bosa L.Di Chiara C.Gaio P.Cosma C.Padoan A.Perilongo G.Giaquinto C.Dona' D.Cananzi M. + FRONTIERS IN PEDIATRICS - -
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5–11 years old children with prior COVID-19 2024 Di Chiara, CostanzaBosa, LucaCosma, ChiaraPagliari, MatteoPalma, PaoloZin, AnnachiaraDe Rossi, AnitaGiaquinto, CarloDona', DanielePadoan, Andrea + VACCINE - -